Inhibition of pancreatic lipase
The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5.
Saved in:
| Main Authors | , , , , |
|---|---|
| Format | Patent |
| Language | English |
| Published |
22.09.2016
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5. |
|---|---|
| AbstractList | The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human beings. Preferably the fraction of guluronate dimers in the alginate is at least 0.5. |
| Author | Wilcox, Matthew David Dettmar, Peter William Brownlee, Iain Andrew Pearson, Jeffrey Peter Richardson, Johnathan Craig |
| Author_xml | – fullname: Richardson, Johnathan Craig – fullname: Dettmar, Peter William – fullname: Brownlee, Iain Andrew – fullname: Pearson, Jeffrey Peter – fullname: Wilcox, Matthew David |
| BookMark | eNrjYmDJy89L5WSQ98zLyEzKLMnMz1PIT1MoSMxLLkpNLMlMVsjJLEgsTuVhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGOoUYGhgbGRkYWJgaOFsbEqQIAlbInaA |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| ExternalDocumentID | AU2010322840A8 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_AU2010322840A83 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:21:32 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_AU2010322840A83 |
| Notes | Application Number: AU20100322840 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160922&DB=EPODOC&CC=AU&NR=2010322840A8 |
| ParticipantIDs | epo_espacenet_AU2010322840A8 |
| PublicationCentury | 2000 |
| PublicationDate | 20160922 |
| PublicationDateYYYYMMDD | 2016-09-22 |
| PublicationDate_xml | – month: 09 year: 2016 text: 20160922 day: 22 |
| PublicationDecade | 2010 |
| PublicationYear | 2016 |
| RelatedCompanies | University of Newcastle upon Tyne RD BioMed Limited |
| RelatedCompanies_xml | – name: University of Newcastle upon Tyne – name: RD BioMed Limited |
| Score | 3.0558274 |
| Snippet | The present invention provides the use of an alginate Io inhibit pancreatic lipase. The use may be directed to the control of weight in animals including human... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Inhibition of pancreatic lipase |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160922&DB=EPODOC&locale=&CC=AU&NR=2010322840A8 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKeqbTkXn1ILSt6JJ09Y-DNnSlinsgmyyt9FkKRZGV7aKf9_T2Ome9hYSyI18OefLuQTgAbVcQj0qLXfuKIspT1l-7CvLljYhnmSxJ0qi2B-4vQl7mzrTGiw2sTA6T-i3To6IiJKI90Lf1_n_I1agfSvXjyLFquVLNG4HZsWOifvkU2oG3XY4GgZDbnKOTNIcvGujL55dpDOd5z3YR0XaK_EQfnTLuJR8W6hEJ3Awwv6y4hRqKmvAEd_8vdaAw35l8sZihb71Gdy9Zp-p0D5WxjIxEMe_Kp80FmmO0ugc7qNwzHsWjjT7W9isM9meln0BdaT86hIMRxCWoKxnQiompSuIzptmM-GiQhYnV9Da1VNzd_M1HJdbVXo9UNqCerH6UjcoWgtxq3fkBw5ves0 |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD7MKc43nYqX6QpK34q2TVv7MGTrhU7XbkgnextNlmJhdMVV_Puexk73tLeQQG7kyzlfziUA96jlqpqlMcVcGFwh3OKKndhc0ZmuqhYjiUUrohhGZjAlLzNj1oDlJhZG5An9FskREVEM8V6K-7r4f8RyhW_l-oFmWLV69uOeK9fsWDUfbU2T3UHPm4zdsSM7DjJJOXoTRl88u0hn-k97sI9KtlXhwXsfVHEpxbZQ8Y_hYIL95eUJNHjehpaz-XutDYdhbfLGYo2-9Sl0h_lHRoWPlbRKJcTxr8rHpGVWoDQ6gzvfi51AwZHmfwub96fb09LPoYmUn1-AZFCVpCjrCWWcMGZSVeRN0wk1USFL0kvo7OrpandzF1pBHI7mo2H0eg1H1bZVHhCa1oFm-fnFb1DMlvRW7M4P-z59wA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Inhibition+of+pancreatic+lipase&rft.inventor=Richardson%2C+Johnathan+Craig&rft.inventor=Dettmar%2C+Peter+William&rft.inventor=Brownlee%2C+Iain+Andrew&rft.inventor=Pearson%2C+Jeffrey+Peter&rft.inventor=Wilcox%2C+Matthew+David&rft.date=2016-09-22&rft.externalDBID=A8&rft.externalDocID=AU2010322840A8 |